- Home
- AXDX vs ICCM Comparison
AXDX vs ICCM Comparison
Compare AXDX & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXDX
- ICCM
- Stock Information
- Founded
- AXDX 1982
- ICCM 2006
- Country
- AXDX United States
- ICCM Israel
- Employees
- AXDX N/A
- ICCM N/A
- Industry
- AXDX Biotechnology: Laboratory Analytical Instruments
- ICCM
- Sector
- AXDX Industrials
- ICCM
- Exchange
- AXDX Nasdaq
- ICCM Nasdaq
- Market Cap
- AXDX 41.8M
- ICCM 45.5M
- IPO Year
- AXDX 1996
- ICCM N/A
- Fundamental
- Price
- AXDX $1.20
- ICCM $1.16
- Analyst Decision
- AXDX Hold
- ICCM Strong Buy
- Analyst Count
- AXDX 1
- ICCM 2
- Target Price
- AXDX $1.00
- ICCM $2.70
- AVG Volume (30 Days)
- AXDX 63.7K
- ICCM 685.1K
- Earning Date
- AXDX 11-07-2024
- ICCM 11-26-2024
- Dividend Yield
- AXDX N/A
- ICCM N/A
- EPS Growth
- AXDX N/A
- ICCM N/A
- EPS
- AXDX N/A
- ICCM N/A
- Revenue
- AXDX $11,909,000.00
- ICCM $3,671,000.00
- Revenue This Year
- AXDX $1.50
- ICCM $18.61
- Revenue Next Year
- AXDX $4.17
- ICCM $54.91
- P/E Ratio
- AXDX N/A
- ICCM N/A
- Revenue Growth
- AXDX N/A
- ICCM 26.02
- 52 Week Low
- AXDX $0.73
- ICCM $0.48
- 52 Week High
- AXDX $4.68
- ICCM $1.57
- Technical
- Relative Strength Index (RSI)
- AXDX 28.60
- ICCM 80.87
- Support Level
- AXDX $1.32
- ICCM $0.79
- Resistance Level
- AXDX $1.42
- ICCM $1.12
- Average True Range (ATR)
- AXDX 0.12
- ICCM 0.07
- MACD
- AXDX -0.04
- ICCM 0.03
- Stochastic Oscillator
- AXDX 10.53
- ICCM 96.51
About AXDX Accelerate Diagnostics Inc.
Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. The firm's core platform, the Accelerate ID/AST System, determines whether live bacterial or fungal cells in a patient sample are susceptible to a particular antibiotic. This test is performed on pathogens that are commonly associated with serious infections and can deliver results more quickly than traditional methods, such as bacterial culturing. The system can analyze a positive blood culture sample in approximately five hours, which is faster than traditional testing techniques. The company earns majority of its revenue from domestic market.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.